Sydney Lupkin
Stories
-
Persistent shortage of growth hormone frustrates parents and clinicians
As a shortage of growth hormone used to treat rare diseases in children drags on, families and doctors are struggling with insurers' requirements to get prescriptions filled.
-
Drugmakers' low U.S. taxes belie their high sales
Most of the largest pharmaceutical companies report losing money in the United States, despite the majority of their sales coming from Americans. The result is lower U.S. taxes for the companies.
-
National
U.S. drug makers see big profits — but many pay taxes far below the corporate rate
Drugmakers make big profits in the U.S. But many pay taxes far below the 21% corporate tax rate. Pfizer's effective tax rate is so low it's getting a big refund despite booking $59 billion in revenue.
-
First over-the-counter birth control pill heads to stores
Women will be able to buy the pill without a prescription later this month at pharmacies and grocery stores.
-
Bayer makes a deal on popular contraceptive with Mark Cuban's online pharmacy
Bayer is adding two of its name-brand drugs to the roster of Cost Plus Drugs: the birth control pill Yaz and the menopause treatment Climara.
-
National
Two Bayer drugs are headed to Mark Cuban's online pharmacy
The online pharmacy of entrepreneur Mark Cuban is adding two brand new Bayer drugs to its disruptor model, which relies on a radical transparency compared to the rest of the industry.
-
FDA approves Florida's plan to import cheaper drugs from Canada
The Food and Drug Administration's authorization of Florida's plan to import prescription medicines from Canada is a first. But the state still has hurdles to clear before imports could begin.
-
How rock-bottom prices drive shortages of generic drugs used in hospitals
Hospitals rely on scores of generic drugs given by injection. But these workhorses are often in short supply. Cheap prices have led to factory closures that leave the supply chain vulnerable.
-
White House proposes to 'march in' on patents for costly drugs
To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.
-
Chronic drug shortages stress hospitals and patients
Pharmacists struggle to find key medicines and now have to anticipate drug shortages caused by extreme weather and global instability.